Aethlon Medical, Inc. (AEMD)
5.15
-0.12
(-2.28%)
USD |
NASDAQ |
Oct 16, 16:00
5.11
-0.04
(-0.78%)
After-Hours: 20:00
Aethlon Medical Enterprise Value : -2.107M for Oct. 16, 2026
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| October 16, 2026 | -2.107M |
| October 15, 2026 | -2.050M |
| October 14, 2026 | -2.155M |
| October 13, 2026 | -1.902M |
| October 12, 2026 | -1.768M |
| October 09, 2026 | -1.678M |
| October 08, 2026 | -1.697M |
| October 07, 2026 | -1.668M |
| October 06, 2026 | -1.659M |
| October 05, 2026 | -1.451M |
| October 02, 2026 | -1.487M |
| October 01, 2026 | -1.401M |
| September 30, 2026 | -1.453M |
| September 29, 2026 | -1.520M |
| September 28, 2026 | -1.520M |
| September 25, 2026 | -1.568M |
| September 24, 2026 | -1.334M |
| September 23, 2026 | -1.315M |
| September 22, 2026 | -1.430M |
| September 21, 2026 | -1.549M |
| September 18, 2026 | -1.554M |
| September 17, 2026 | -1.329M |
| September 16, 2026 | -3.883M |
| September 15, 2026 | -3.864M |
| September 14, 2026 | -3.831M |
| Date | Value |
|---|---|
| September 11, 2026 | -3.836M |
| September 10, 2026 | -3.821M |
| September 09, 2026 | -3.759M |
| September 08, 2026 | -3.702M |
| September 04, 2026 | -3.697M |
| September 03, 2026 | -3.645M |
| September 02, 2026 | -3.697M |
| September 01, 2026 | -3.688M |
| August 31, 2026 | -3.583M |
| August 28, 2026 | -3.377M |
| August 27, 2026 | -3.53M |
| August 26, 2026 | -3.478M |
| August 25, 2026 | -3.420M |
| August 24, 2026 | -3.306M |
| August 21, 2026 | -3.263M |
| August 20, 2026 | -3.277M |
| August 19, 2026 | -3.239M |
| August 18, 2026 | -3.186M |
| August 17, 2026 | -3.165M |
| August 14, 2026 | -3.215M |
| August 13, 2026 | -3.167M |
| August 12, 2026 | -3.115M |
| August 11, 2026 | -3.048M |
| August 10, 2026 | -3.096M |
| August 07, 2026 | -3.062M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| Abbott Laboratories | 209.16B |
| AngioDynamics, Inc. | 453.62M |
| Alphatec Holdings, Inc. | 2.106B |
| AtriCure, Inc. | 2.758B |
| Baxter International, Inc. | 19.75B |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -1.548M |
| Total Expenses (Quarterly) | 1.548M |
| EPS Diluted (Quarterly) | -4.024 |
| Earnings Yield | -795.9% |
| Normalized Earnings Yield | -795.87 |